These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38330687)
1. High rates of myocarditis with clozapine in the Hunter region of Australia. Tirupati S; Arachchi MK Schizophr Res; 2024 Feb; 264():543-548. PubMed ID: 38330687 [TBL] [Abstract][Full Text] [Related]
2. Clozapine-induced myocarditis during co-administration of valproate: A case report. Jahołkowski P; Niewiadomska J; Wciórka J; Kowalski M; Świtaj P Psychiatr Pol; 2019 Oct; 53(5):997-1002. PubMed ID: 31955181 [TBL] [Abstract][Full Text] [Related]
3. When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. Qubad M; Dupont G; Hahn M; Martin SS; Puntmann V; Nagel E; Reif A; Bittner RA CNS Drugs; 2024 Sep; 38(9):671-696. PubMed ID: 38951464 [TBL] [Abstract][Full Text] [Related]
4. A comparative study of detection of myocarditis induced by clozapine: With and without cardiac monitoring. Anıl Yağcıoğlu AE; Ertuğrul A; Karakaşlı AA; Ağaoğlu E; Ak S; Karahan S; Yazıcı MK Psychiatry Res; 2019 Sep; 279():90-97. PubMed ID: 31362146 [TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia. Youssef DL; Narayanan P; Gill N Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457 [TBL] [Abstract][Full Text] [Related]
6. Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review. Noël MC; Powell V; Burton L; Panda R; Remington G J Clin Psychopharmacol; 2019; 39(4):380-385. PubMed ID: 31205188 [TBL] [Abstract][Full Text] [Related]
7. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research. de Leon J J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145 [TBL] [Abstract][Full Text] [Related]
8. Myocarditis and cardiomyopathy associated with clozapine. Kilian JG; Kerr K; Lawrence C; Celermajer DS Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719 [TBL] [Abstract][Full Text] [Related]
9. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003. Haas SJ; Hill R; Krum H; Liew D; Tonkin A; Demos L; Stephan K; McNeil J Drug Saf; 2007; 30(1):47-57. PubMed ID: 17194170 [TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy. Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459 [TBL] [Abstract][Full Text] [Related]
11. Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Hollingworth SA; Winckel K; Saiepour N; Wheeler AJ; Myles N; Siskind D Psychopharmacology (Berl); 2018 Jul; 235(7):1915-1921. PubMed ID: 29589067 [TBL] [Abstract][Full Text] [Related]
12. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Reinders J; Parsonage W; Lange D; Potter JM; Plever S Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025 [TBL] [Abstract][Full Text] [Related]
13. Clozapine and incidence of myocarditis and sudden death - Long term Australian experience. Khan AA; Ashraf A; Baker D; Al-Omary MS; Savage L; Ekmejian A; Singh RSH; Brienesse S; Majeed T; Gordon T; Drinkwater V; Collins NJ Int J Cardiol; 2017 Jul; 238():136-139. PubMed ID: 28343762 [TBL] [Abstract][Full Text] [Related]
15. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ Schizophr Res; 2011 May; 128(1-3):161-5. PubMed ID: 21320766 [TBL] [Abstract][Full Text] [Related]
16. A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration. Carswell O; Wilton LR; Nicholls K; Thomas V; Clark SR Schizophr Res; 2024 Jun; 268():88-93. PubMed ID: 37722933 [TBL] [Abstract][Full Text] [Related]
17. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; Wolfe R; McNeil JJ Schizophr Res; 2012 Nov; 141(2-3):173-8. PubMed ID: 23010488 [TBL] [Abstract][Full Text] [Related]
18. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series. Ertuğrul A; Anıl Yağcıoğlu AE; Ağaoğlu E; Karakaşlı AA; Ak S; Yazıcı MK; de Leon J Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):281-286. PubMed ID: 36513403 [TBL] [Abstract][Full Text] [Related]
19. Is the higher incidence of clozapine induced myocarditis in Australia due to awareness and monitoring? Dawson JL; Clark SR; Sluggett JK; Procter NG; Bell JS Schizophr Res; 2018 Nov; 201():426-427. PubMed ID: 29907491 [No Abstract] [Full Text] [Related]
20. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital. Higgins JM; San C; Lagnado G; Chua D; Mihic T Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]